You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
鍾南山估算內地有11億至12億人曾感染新冠
據《中新社》報道,中國工程院院士鍾南山昨日(15日)下午出席一個場合時稱,無論有症狀還是沒有症狀,如果體內冠病病毒對應的抗體增高,就說明人體曾被感染過。從這個角度看,根據測定,全國料有85%的人曾感染新冠,約有11億至12億人。 目前在廣州流行的主流冠病病毒株是XBB1.9.1。根據目前廣州市發熱門診的數據,在接受檢測的發熱病人裡,有20%至25%是新冠病毒感染者。 鍾南山認為,此前各地預測今年4月底到5月初會有一個疫情小高峰。從觀察情況來看,大部分人已全劑量接種了疫苗,起到了很好的防重症作用。 展望未來,他表示,一方面還需要研發能覆蓋XBB變異毒株的疫苗,包括mRNA疫苗和重組蛋白疫苗,這些疫苗主要是要針對一些特殊人群,比如免疫低下或有其他長期病的老年人;另一方面,一旦感染了新冠,應給予及時藥物治療,能大大降低死亡率。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account